Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Dynavox Group AB | DYVOX | Nov 25, 2024 | 62.50 | +1.46 |
Eastnine | EAST | Nov 25, 2024 | 42.48 | -1.21 |
EasyFill B | EASYB | Nov 25, 2024 | 0.16 | -8.57 |
EatGood | EATG | Nov 25, 2024 | 0.52 | +18.37 |
eBlitz Group | EBLITZ | Nov 25, 2024 | 1.16 | -1.69 |
Ecoclime Group B | ECCB | Nov 25, 2024 | 1.99 | +3.39 |
EcoRub B | ECOB | Nov 25, 2024 | 0.12 | -5.98 |
Edyoutec AB | EDYOU | Nov 25, 2024 | 1.06 | -2.03 |
eEducation Albert | ALBERT | Nov 25, 2024 | 3.69 | -0.27 |
Eevia Health | EEVIA | Nov 25, 2024 | 0.23 | +3.59 |
Effnetplattformen Holding | EFFH | Nov 25, 2024 | 6.75 | +48.68 |
Egetis Therapeutics | EGTX | Nov 25, 2024 | 5.64 | +5.62 |
Elanders B | ELANB | Nov 25, 2024 | 89.90 | +0.56 |
Electrolux A | ELUXA | Nov 25, 2024 | 98.00 | +2.08 |
Electrolux B | ELUXB | Nov 25, 2024 | 83.16 | +2.67 |
Electrolux Professional B | EPROB | Nov 25, 2024 | 65.50 | -0.46 |
Elekta B | EKTAB | Nov 25, 2024 | 64.30 | +1.90 |
Elicera Therapeutics | ELIC | Nov 25, 2024 | 1.71 | -1.44 |
Ellen | ELN | Nov 25, 2024 | 1.08 | +1.89 |
Ellwee | ELLWEE | Nov 25, 2024 | 4.01 | -2.67 |
Elmera Group | ELMRAO | Nov 25, 2024 | 39.15 | +2.89 |
Elon AB (publ) | ELON | Nov 25, 2024 | 25.80 | +6.17 |
Eltel | ELTEL | Nov 25, 2024 | 6.60 | 0.00 |
Embark Group | EMB | Nov 25, 2024 | 0.52 | +20.93 |
EmbeddedArt Group AB (publ) | EMART | Nov 25, 2024 | 7.01 | -2.64 |
Embellence Group | EMBELL | Nov 25, 2024 | 30.20 | +0.33 |
Embracer Group B | EMBRACB | Nov 25, 2024 | 28.92 | +4.97 |
Emilshus | EMILPREF | Nov 25, 2024 | 30.40 | +0.33 |
Emilshus B | EMILB | Nov 25, 2024 | 45.30 | -0.44 |
Enad Global 7 | EG7 | Nov 25, 2024 | 13.98 | +7.54 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.